intraoperative blood salvage
autologous blood transfusion
cell salvage

This procedure is known as "Intraoperative Blood Salvage."

In some surgical procedures (especially some heart operations) where substantial blood loss is expected, machinery is used for intraoperative blood salvage.

Intraoperative blood salvage is a technique which recycles and cleans blood from a patient during an operation and redirects it into the patient's body.

Intraoperative blood salvage has been used for many years, especially in cardiothoracic and vascular surgery, where blood usage has traditionally been high.

They are commonly called "Autos" by blood bank personnel, and it is one major form of the more general concept of autotransfusion (the other being intraoperative blood salvage).

Intraoperative blood salvage (autologous) or cell-saver scavenging, a method of picking up blood that has spilled from the circulatory system into an open wound, cleaning and re-infusing it.

Intraoperative blood salvage, also known as autologous blood transfusion or cell salvage, is a medical procedure involving recovering blood lost during surgery and re-infusing it into the patient.

There are two main kinds of autotransfusion: Blood can be autologously "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device (such as a Cell Saver).

This unsophisticated method resulted in a 75% mortality rate, but it marked the start of autologous blood transfusion.

The practice of donating one's own blood before surgery and then receiving it during or shortly thereafter is called autologous blood transfusion.

Blood leaving the body of a human or animal must be disposed of, except for autologous blood transfusions considered part of a "current therapy".

The company initially released a line of anesthesia and respiratory care instruments, followed by suction regulators and autologous blood transfusion products.

These unusual levels were not present in the routine test, leading to suspicions that Di Luca had received an autologous blood transfusion between the two tests.

However the first documented use of autologous blood transfusion was in 1818 when an Englishman, Blundell, salvaged vaginal blood from patients with postpartum hemorrhage.

Through the publicity given to autologous blood transfusions, partly by Mr. Reagan and partly by medical leaders, the practice is catching on with a growing number of people.

Autologous blood transfusions can also be used in many other elective operations, like plastic surgery, or for scheduled operations, like cancer surgery, that may involve extensive blood loss.

Intraoperative blood salvage, also known as autologous blood transfusion or cell salvage, is a medical procedure involving recovering blood lost during surgery and re-infusing it into the patient.

In contrast, the older forms of liposuction used before the invention of the tumescent technique were associated with so much surgical blood loss that autologous blood transfusions were often routine.

Autologous blood transfusions now account for about 2 percent of transfusions in this country, though the frequency of use varies among medical centers and the interest of physicians and blood bank officials.

However bloodless medical and surgical techniques have limitations, and surgeons say the use of various allogeneic blood products and/or pre-operative autologous blood transfusion is the standard of care for some patient presentations.

Many doctors view acute normovolemic hemodilution, a form of storage of a patient's own blood, as a pillar of "bloodless surgery" but the technique is not an option for patients who refuse autologous blood transfusions.

By emphasizing the benefits of autologous blood transfusions, Dr. Silvergleid said, "we realize we are giving out a message that the alternative of community blood is not as good; it is not a large degree worse, it is different."

Two days later, the Italian State Police confirmed that they were investigating Riccò for blood doping, after an apparent self-administered autologous blood transfusion at his home, and obtained his medical records while Riccò was in hospital recovering.

Despite admitting throughout the work that he very regularly used EPO, testosterone pills and patches, and autologous blood transfusions (all banned practices), Hamilton staunchly opposed the sanction, since he had never used the blood of another person.

Mosquera had tested positive for hydroxyethyl starch at the 2010 Vuelta a España, while Riccò had been admitted to hospital earlier in February, amid allegations that he had carried out a self-administered autologous blood transfusion at his home.

Allegations include the assertion that Bruyneel was part of a long-running doping conspiracy, including the use of erythropoietin, autologous blood transfusions, anabolic steroids, human growth hormone, and other banned methods to augment the performance of the cycling teams which he directed.

The acquisition included (i) Dideco, an Italian company that was the European leader in the market for extracorporeal blood circulation and autologous blood transfusion products, and (ii) Stöckert, a leading world producer and distributor of heart-lung machines, as well as their subsidiaries.

Cell salvage and autotransfusion can also be used as treatment.

Intraoperative blood salvage, also known as autologous blood transfusion or cell salvage, is a medical procedure involving recovering blood lost during surgery and re-infusing it into the patient.

When a patient's own blood is salvaged and reinfused during a surgery (e.g. using a cell salvage machine such as a Cell Saver), this can be considered a form of autotransfusion (and thus a form of transfusion) even though no "blood product" is actually created.